Florida Gulf Coast University
Fort Myers, Florida, 33965, United States
NCT Number: NCT04775628
This study evaluates the force and translation distance in the GH joint during a manual inferior glide of the humerus.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Fort Myers, Florida, 33965, United States
There has been limited research on how the variance of force affects MT outcomes and what the best practices of MT should be. No specific force threshold necessary to achieve a predetermined translational distance within the joint has been quantified within the literature. The purpose of this study was to quantify the amount of force necessary to perform an inferior glide to the glenohumeral joint and reach to end-range. A secondary aim was to determine the impact of co-variables, such as gender, height, weight, and age, on the amount of force required to translate the humeral head within the glenohumeral joint. Musculoskeletal Ultrasound imaging using the GE LogiQe was used to measure the translation of the humeral head. The manipulation force was measured using the Novel Pliance Glove device and software.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supine inferior glide GH joint
Time frame: 5 minutes
Measured in mm using MSK Ultrasound
Time frame: 5 minutes
Force measure during inferior glide using Novel Pliance Glove
Dr. Rob Sillevis,
Other
Forces and Translation Distance During an Inferior Glide of the Shoulder in Healthy Subjects Measured With the Novel Pliance Glove and Ultrasound Imaging
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06705192
Asymptomatic Condition, Asymptomatic Diseases
Rotterdam, Netherlands
View Trial DetailsNCT06048237
Asymptomatic Condition, Asymptomatic Diseases
Pátrai, Achaia, Greece
View Trial DetailsNCT05899244
Asymptomatic Condition, Asymptomatic Diseases
Liège, Liege, Belgium
View Trial DetailsNCT05210231
Asymptomatic Condition, Asymptomatic Diseases
Rosario, Santa Fe Province, Argentina
View Trial Details